Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Q&A With Scott Whitaker: AdvaMed's Next CEO On The Path Ahead

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed's board just selected Scott Whitaker, a top executive at the Biotechnology Innovation Organization, as the trade group's next CEO. Before he starts in the new role on April 4, he spoke with The Gray Sheet about his vision.


Related Content

Conference Collaboration Sign Of Growing AdvaMed, MDMA Partnership
Next AdvaMed Chief Is BIO Exec Scott Whitaker





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts